U.S. FDA declines to approve Amryt's rare skin disease treatment

 Amryt Pharma said on Monday the U.S. Food and Drug Administration declined to approve the company's drug for the treatment of a group of rare skin diseases.

The agency has asked Amryt to submit additional data confirming effectiveness of the drug.

https://www.marketscreener.com/quote/stock/AMRYT-PHARMA-PLC-66481723/news/U-S-FDA-declines-to-approve-Amryt-s-rare-skin-disease-treatment-39611637/